Emergency use nod sought for ZyCoV-D
The Hindu
It will be the world’s first plasmid DNA vaccine for COVID-19, says Zydus Cadila
Zydus Cadila said it has applied to the Drug Controller General of India (DCGI) seeking Emergency Use Authorisation (EUA) for ZyCoV-D, its plasmid DNA vaccine to counter COVID-19. It will be the world’s first plasmid DNA vaccine for COVID-19, the company said. The company had conducted clinical trials at over 50 centres in India, it said. Phase III clinical trials had been conducted on over 28,000 volunteers. This was the first time that any COVID-19 vaccine had been tested in adolescent population in the age group of 12-18 years in India.More Related News